Regular Article
Sphingomyelinases in cell regulation

https://doi.org/10.1006/scdb.1997.0153Get rights and content

Abstract

Sphingomyelin hydrolysis and ceramide generation have emerged as key events in cellular regulation. Sphingomyelinases (SMases) catalyse the breakdown of sphingomyelin to form ceramide and phosphorylcholine. Ceramide formed through activation of SMases may function as a second messenger in mediating cell growth, differentiation, stress responses, and programmed cell death (apoptosis). So far, five types of SMases have been described and they include the acidic, the acidic zinc-dependent, the neutral magnesium-dependent, the neutral magnesium-independent, and the alkaline SMase. These SMases differ in tissue distribution, cofactor dependence, mechanism for regulation, and involvement in diverse cellular processes. At least two of these sphingomyelinases may regulate the intracellular levels of ceramide and subsequent ceramide-mediated responses. This review will focus on the identification, regulation and roles of SMases in cell function.

References (0)

Cited by (131)

  • Targeted lipidomics reveal derangement of ceramides in major depression and bipolar disorder

    2019, Metabolism: Clinical and Experimental
    Citation Excerpt :

    The latter revealed that the abundance of SMPD1 (gene encoding acidic sphingomyelinase, ASM) splice variants, which encode for enzymatically low-active “protective” ASM variants were rarely found in MD patients [54]. In line with this conclusion, a number of antidepressants and antipsychotic agents are functional inhibitors of ASM, called FIASM [53,55], which converts sphingomyelin to ceramides at the inner lysosomal membrane and plasma membrane, hence contributing to sphingomyelin degradation and ceramide production in the lysosome [15,56]. Although loss of function mutations of ASM in Niemann-Pick disease are obviously detrimental and lead to a lysosomal storage disease [57], it has been proposed that moderate or transient inhibition of ASM is of therapeutic value for a number of diseases including major depression [53] and cancer [58,59].

  • Brain metabolic dysfunction at the core of Alzheimer's disease

    2014, Biochemical Pharmacology
    Citation Excerpt :

    Ceramides accumulate in cells due to disturbances in sphingolipid metabolism [67,199–201] and upregulation of pro-ceramide genes [110,202]. Altered sphingolipid metabolism aberrantly increases intracellular ceramide levels and insulin resistance [113,136,199,200,203–205] in obesity, T2DM, NASH, and AD [81,82,146,190–196]. Since none of the experimental models of peripheral insulin resistance were associated with substantial alterations ceramide-related gene expression or enzymatic activity in brain, if toxic ceramides were to mediate disease, they must originate from sources outside of the CNS.

  • Modulation of Hepatic Apoptotic Pathways by Dietary Olive and Sunflower Oil

    2010, Olives and Olive Oil in Health and Disease Prevention
View all citing articles on Scopus
View full text